CClinicalTrials.gg
CompletedNCT04458506Updated Nov 18, 2023

Treatment of Unilateral Posterior Cross Bite in Children

An interventional study of Maxillary expansion in Malocclusion, Maxillary Expansion and Pain Children, sponsored by Region Örebro County. Completed at 1 site in Sweden. Open to participants aged 8 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Region Örebro County · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled May 2019, registered Jun 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
8 Years to 13 Years
Sex
All
01

Study summary

Rapid maxillary expansion and quad-helix are two well established appliances in dentistry used for posterior cross bite treatment. This study aims to compare this two different appliances in patients in their early mixed dentition, regarding treatment effects of the extra oral soft tissue but also dental and skeletal effects, if the children experience any pain and discomfort during treatment and the study also aims to make a cost minimization analysis. Comparison of these different treatments are barely made and no randomized controlled trial is yet published. No study has evaluated the difference of subjective experience during these two treatments. After this study we will know which one of these two appliances are the most effective, regarding cost minimization and treatment result but we are also able to put it in relation to the patients subjective experience

02

Conditions studied

  • Malocclusion
  • Maxillary Expansion
  • Pain Children

Browse trials for

03

In context

Malocclusion

457 studies on the registry are indexed under Malocclusion; 89 are open to participants now.

This study's enrollment of 72 is above the median of 36 across 372 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Region Örebro County is the lead sponsor of 123 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children in the early mixed dentition
  • Unilateral posterior cross bite including the first permanent molar

Exclusion criteria

Exclusion Criteria:

  • No ongoing sucking habits
  • Craniofacial syndroms
  • Earlier Orthodontic treatments
  • Not able to independently understand and answer the questionnaires
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Rapid Maxillary Expander (RME)

    36 patients will be treated with RME in order to correct their unilateral posterior cross bite

    Procedure: Maxillary expansion

  • Active comparator
    Quad Helix (QH)

    36 patients will be treated with QH in order to correct their unilateral posterior cross bite

    Procedure: Maxillary expansion

Interventions

  • ProcedureMaxillary expansion

    Correction of the unilateral posterior cross bite in children

06

What researchers measure

Primary outcomes

  1. Skeletal expansion at the level of the palatal median suture - the change fram Baseline

    Skeletal expansion evaluated by computed tomography at three time points in both arms. The change in width of the palatal median suture is going to be evaluated and compared to the Baseline values, in both arms.

    Time frame: At baseline, directly after expansion and one year after expansion

  2. The change of inclination of teeth and alveolar bone and side effects between the time points

    Dental effects and side effects evaluated by computed tomography at three time points in both arms.The change in degree of angulation and inclination of the dental structures (e.g. tooth inclinations) is going to be evaluated and compared to the Baseline values, in both arms.

    Time frame: At baseline, directly after expansion and one year after expansion

Secondary outcomes

  1. Assessment of the soft tissue changes

    3D assessment of the soft tissue changes during and after treatment by 3D -photography

    Time frame: At baseline, directly after expansion, six months and one year after expansion

  2. Evaluation of pain and discomfort

    Questionnaire The Questionnaire has some questions with Visual Analogue Scale. With the minimum value of "0" and maximum value of "10". Higher values mean worse outcome. Other questions in the questionnaire have a "yes" and "No" nature.

    Time frame: Three times during the first week after inserting the appliances

  3. Evaluation of Temporomandibular Disorder (TMD)

    Questionnaire The questionnaire has no scale and the questions have a "Yes" och "No" nature.

    Time frame: Baseline and one year after expansion

  4. Cost-effectiveness of two treatment modalities in treatment of posterior cross bite

    Evaluation of both the direct and indirect costs of the treatment, number of emergency visits, treatment duration (in total) etc are going to be evaluated.

    Time frame: Through study completion, an average of 18 months

07

Study locations

1 site
  • Postgraduate Dental Education Center
    Örebro, SE-70111, Sweden
08

References and documents

Publications

  • Petren S, Bondemark L, Soderfeldt B. A systematic review concerning early orthodontic treatment of unilateral posterior crossbite. Angle Orthod. 2003 Oct;73(5):588-96. doi: 10.1043/0003-3219(2003)0732.0.CO;2. PubMed 14580028 ↗
  • Hansson S, Josefsson E, Lindsten R, Magnuson A, Bazargani F. Pain and discomfort during the first week of maxillary expansion using two different expanders: patient-reported outcomes in a randomized controlled trial. Eur J Orthod. 2023 May 31;45(3):271-280. doi: 10.1093/ejo/cjac067. PubMed 36331513 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04458506
Lead sponsor
Region Örebro County
Collaborators
Region Jönköping County
Responsible party
Sponsor
First posted
Jul 7, 2020
Start date
May 13, 2019
Primary completion
Oct 1, 2022
Completion
Nov 1, 2022
Last update
Nov 18, 2023

Study contacts

Farhan Bazargani, DDS, PhD
study director · Örebro University, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion